MDI Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- MDI Therapeutics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06453824
- Locations
- 🇺🇸
1951 NW 7th Avenue, Suite 180, Miami, Florida, United States
News
No news found